Congestion
15
4
4
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
6.7%
1 terminated out of 15 trials
80.0%
-6.5% vs benchmark
20%
3 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (15)
Training Medical Residents in the Use of the Venous Excess UltraSound (VExUS) Score for Bedside Volume Assessment.
Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention
Portal Vein Flow Variability to Quantify Right-Sided Hemodynamic Congestion (PORTAL)
Optimization of Fluid Balance Guided by Bioelectrical Impedance Analysis in Patients Undergoing Continuous Renal Replacement Therapy in Critical Care
PVP-Guided Decongestive Therapy in HF 2
Determinants of Portal Vein Pulsatility Index
Sodium Chloride vs. Glucose Solute as a Volume Replacement Therapy During Decongestion in Acute Heart Failure
Biomarkers for the Assessment of Congestion in Patients With Ambulatory and Hospitalised Heart Failure
SUbCONgestion in Heart Failure Registry
Ultrasound-guided Treatment in Acute Heart Failure
Alleviation of Common Cold Symptoms
ERTU-SODIUM: Study on the Effects of Ertugliflozin on Sodium Storage, Interstitial Volume, and Plasma Volume in HFrEF
ClearUP Longitudinal Pilot Study
Comparison of Non-invasive to Invasive Assessment of Jugular Venous Pressure
VoIce Changes and Heart Failure